SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending following the successful orbital launch of its BlueBird 6 satellite, the largest commercial communications array ever deployed in low Earth orbit, validating its direct-to-device 5G technology. While some traders are taking profits in a "sell the news" reaction, many in the community view this as a pivotal de-risking event, anticipating significant future growth and a potential short squeeze as the company moves towards commercial scalability.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros is trending due to the FDA's historic approval of YARTEMLEA, its first and only therapy indicated for TA-TMA, a serious complication of stem cell transplantation, which includes a broad pediatric label. The community is highly optimistic, anticipating a significant short squeeze and potential for substantial price appreciation given the drug's unique position. Discussion is also focused on the prolonged trading halt and future buyout prospects with existing partners like Novo Nordisk.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is trending as Apple CEO Tim Cook's recent stock purchase sparks significant community discussion, viewed by many as a strong vote of confidence in the company. While some dismiss the insider buy as insignificant, others believe it signals a potential turnaround for the sportswear giant, which has faced headwinds from China sales and tariff concerns.

Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the provision of discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.

Dynavax Technologies Corp.

Dynavax is trending as Sanofi has announced an all-cash agreement to acquire the company, offering a significant premium for its leading hepatitis B vaccine and promising shingles pipeline. The community is actively celebrating the immediate gains for shareholders, though some express sentiment that the valuation is conservative, fueling speculation about potential competing bids. This acquisition highlights Sanofi's strategic expansion in adult vaccines and reflects the ongoing M&A activity within the biotech sector.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum Holdings is a trending topic amidst surging demand for its critical optical solutions, including co-packaged optics and high-speed transceivers, essential for the rapidly expanding AI data center infrastructure. The community is actively discussing strong analyst upgrades and robust earnings guidance, with many speculating on the company's significant undervaluation and potential as an acquisition target.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

The iShares Silver Trust (SLV) is experiencing intense bullish momentum, driven by spot silver prices reaching new all-time highs. This rally is fueled by tightening global supply due to upcoming Chinese export restrictions, alongside booming industrial demand from EV batteries, solar, and AI data centers. The community is actively discussing a potential 'silver squeeze' and a significant re-rating of silver's value, though some anticipate a near-term pullback after its rapid ascent.

Aimei Health Technology Co., Ltd. is a blank check company, which engages in entering a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. The company was founded on April 27, 2023 and is headquartered in New York, NY.

Aimei Health Technology Co Ltd

Aimei Health Technology Co Ltd ($AFJK) is trending due to its extremely low float and high cost to borrow, sparking intense community discussion about a potential short squeeze and dramatic price swings. Many traders are comparing its parabolic moves to other recent volatile low-float runners, while a mixed sentiment persists regarding its speculative nature following a blank check merger with a Chinese company.

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Agios Pharmaceuticals Inc

Agios Pharmaceuticals is trending due to the recent US FDA approval of AQVESME (mitapivat) for treating anemia in adults with alpha- or beta-thalassemia, marking it as the first and only oral medicine for this condition. The community is actively discussing the significant market opportunity and potential future valuations following this landmark regulatory catalyst.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is actively trending as investors voice deep frustration with management's perceived inaction to secure partnerships, especially for its combination flu/COVID vaccine, a sentiment exacerbated by a competitor's recent acquisition. The community debates whether leadership's prolonged silence signals advanced buyout discussions or a strategic misstep, particularly as potential regulatory scrutiny on mRNA vaccines could highlight Novavax's protein-based platform as a differentiated alternative.

Citigroup, Inc. is a holding company, which engages in the provision of financial products and services. It operates through the following segments: Services, Markets, Banking, Wealth, U.S. Personal Banking (USPB), and All Other. The Services segment includes Treasury and Trade Solutions (TTS) which provides an integrated suite of tailored cash management, trade, and working capital solutions to multinational corporations, financial institutions and public sector organizations, and Securities Services, which offers cross-border support for clients, providing on-the-ground local market expertise, post-trade technologies, customized data solutions, and a wide range of securities services solutions that can be tailored to meet client needs. The Markets segment provides corporate, institutional, and public sector clients around the world with a full range of sales and trading services across equities, foreign exchange, rates, spread products, and commodities. The Banking segment offers Investment Banking and Corporate Lending services. The Wealth segment includes Private Bank, Wealth at Work, and Citigold and provides financial services to a range of client segments through banking, lending, mortgages, investment, custody, and trust product offerings. The USPB segment includes Branded Cards and Retail Services, which have proprietary card portfolios and co-branded card portfolios within Branded Cards, and co-brand and private label relationships within Retail Services. The All Other segment consists of activities not assigned to the reportable operating segments, including certain unallocated costs of global functions, other corporate expenses, and net treasury results. The company was founded in 1812 and is headquartered in New York, NY.

Citigroup Inc

Citigroup is seeing significant buzz driven by recent regulatory tailwinds and concrete progress on its multi-year strategic overhaul, including its Banamex divestiture. This momentum has led to new highs, with many investors anticipating further upside within a strengthening financial sector, though community sentiment also reflects caution about potential overbought conditions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

FuelCell Energy (FCEL) shares jumped as much as 29% at the opening bell on&nbsp;Friday after&nbsp;the company reported a surge in revenue&nbsp;and laid out a major restructuring plan to reduce costs and concentrate on its carbonate platform.FuelCell Energy reported a loss of $1.79 per share in the second quarter (Q2), an improvement over the same period last year and&nbsp;wider than the estimated loss of $1.38 per share, according to Koyfin data.Its revenue grew 67% year-on-year (YOY) to $37.4 million, coming in ahead of Wall Street’s estimate of $32 million. Management said the growth was driven by new product and&nbsp;service contract activity.&nbsp;Product revenue was $13 million compared with none in the prior-year period, while service agreements generated $8.1 million, helped by module replacements under a contract with United IlluminatingGeneration revenue declined to $12.1 million from $14.1 million, reflecting lower power output due to maintenance. Advanced technologies contract revenue also fell to $4.1 million from $6.9 million,&nbsp;partly due to reduced revenue from contracts with ExxonMobil affiliates and government agencies.The company announced a new restructuring initiative&nbsp;that will affect operations in the U.S., Canada, and Germany.&nbsp;FuelCell said the move is intended to reduce operating costs, prioritize carbonate platform development, and preserve competitiveness in a slower investment environment for clean energy.&nbsp;The plan includes a 22% reduction in workforce, bringing global headcount to approximately 426.This follows a November 2024 restructuring that targeted a 15% reduction in fiscal 2025 operating costs and included a 13% workforce cut along with trimmed spending on product development and overhead.CEO Jason Few said the company is prioritizing its core carbonate technology in response to demand from AI data centers and distributed power solutions. FuelCell is also scaling back commercial development of solid oxide platforms and trimming SG&amp;A expenses to improve its financial trajectory.CFO Michael Bishop&nbsp;highlighted the company’s ongoing cost discipline and pursuit of strategic financing.&nbsp;Cash and equivalents, including restricted cash and short-term investments, totaled $240 million at the end of the quarter, down from $318 million in October 2024.FuelCell ended the quarter with $1.26 billion in backlog, up 19% from a year earlier, supported by a long-term service agreement with Gyeonggi Green Energy in South Korea and a new 20-year power purchase agreement for a 7.4-MW fuel cell plant in Connecticut.<a href="https://stocktwits.com/symbol/FCEL">FuelCell’s stock</a> is down 77% over the past 12 months and 30% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-not-interested-in-call-with-elon-musk-say-reports/chkzrevRbUc">Trump ‘Not Interested’ In Call With Elon Musk, Say Reports</a>

The JFB Fuel Cell Power Plant, manufactured by FuelCell Energy, Inc., is unveiled at the headquarters (L) of the Los Angeles Department of Water and Power March 14, 2003 in Los Angeles, California. (Photo by David McNew/Getty Images)

FuelCell Stock Jumps Despite Q2 Earnings Miss On Revenue Surge, New Restructuring Plan

FuelCell’s restructuring plan includes a 22% reduction in workforce, bringing global headcount to approximately 426.

Current Price	$29.06
Prev Close	$29.02
Open	$29.10
Dividend Yield	N/A
50-Day Moving Average	$30.35
Beta	N/A
Avg. Volume	9,910.84
PE Ratio	N/A

52-Week High	$32.85
52-Week Low	$18.44
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

IBAT
iShares Energy Storage & Materials ETF

Feed

News

Sentiment

Fundamentals

Info

Latest IBAT News

IBATiShares Energy Storage & Materials ETF